22/05/2024  18:14:28 Chg. - Volume Bid- Demandez à- Capitalisation boursière Dividende Y. Rapport P/E
188.00EUR - -
Chiffrre d'affaires: -
-Bid taille: - -Ask la taille: - 15.02 Mrd.EUR - -

Description de l'entreprise

Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
 

Conseil d'administration & Conseil de surveillance

PDG
Adam Schechter
Conseil d'administration
Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson
Conseil de surveillance
Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D.
 

Données de l'entreprise

Nom: Laboratory Corporation of America Holdings
Adresse: 531 South Spring Street,Burlington, North Carolina 27215, USA
Téléphone: +1-336-229-1127
Fax: +1-336-436-1569
Courriel: -
Internet: https://www.labcorp.com/
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 31/12
Flotte libre: 78.40%
IPO date: -

Relations avec les investisseurs

Nom: Chas Cook
Téléphone IR: +1-336-436-5076
IR-Fax: 336-436-1569
E-mail IR: investor@labcorp.com

Calendrier de l'entreprise

CW 24 | 12/06/2024 Dividend Payment